300601-基本财务实时评分详情
康泰生物300601基本财务实时评分详情
更新时间:2021-02-27 00:00:01
股票代码
300601
当期评分
股票名称
康泰生物
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)0.52690.78380.74870.74870.7487
销售净利润率(%)21.601729.562930.50930.50930.509
销售毛利率(%)90.564391.046992.342392.342392.3423
净资产收益率(%)23.7720.866.256.256.25
营业增长率(%)73.6949-3.64771.87221.87221.8722
净利润增长率(%)102.924131.86260.57730.57730.5773
每股收益(%)0.70.910.66160.40220.0038
现金流量比率(%)34.54558.114637.01923.1597-9.6018
三项费用比重(%)58.451449.438347.989347.905568.3497
每股净资产(¥)2.87024.268710.16139.62044.321
流动比率(%)1.78662.10093.93465.72272.2022
速动比率(%)1.58531.83813.66395.35941.8347
现金比率(%)65.153358.059292.044189.468789.4687
总资产利润率(%)15.708415.76396.96254.56230.0618
主营利润比重%373.4689266.689260.8692268.29285116.5135
应收账款(万元)85,546.61105,002.19141,121.97133,768.09102,797.58
应收票据(万元)229.8870.00141.0618.80116.56
预付款项(万元)979.091,231.397,640.834,468.751,781.49
存货(万元)19,608.6722,875.9637,209.6129,885.0528,911.17
在建工程(万元)61,560.8446,228.5860,951.9242,476.3747,062.79
应付款项(万元)9,170.5611,657.059,670.499,663.4911,164.14
长期借款(万元)25,501.8319,501.831,979.55--18,001.83
未分配利润(万元)61,671.6899,017.51122,175.91124,998.5899,259.93
商誉(万元)----------
流动资产(万元)159,621.37212,421.28308,566.92272,945.08215,737.38
流动负债(万元)97,402.4187,017.93137,485.9482,261.8878,660.30
康泰生物300601评分结果
63.64分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006